Evercore ISI Group analyst Joshua Schimmer downgrades Seagen (NASDAQ:SGEN) from Outperform to In-Line and raises the price target from $175 to $229.
A Look Into Boston Scientific Inc’s Price Over Earnings
In the current session, the stock is trading at $55.67, after a 0.64% spike. Over the past month,…